Journal of Vaccines & Vaccination

Department of Internal Medicine, Section of Infectious Diseases, Aga Khan University, Karachi, Pakistan

Biography

Dr. Mahmood is an Assistant Professor of Pathology at Harvard Medical School and the Division of Computational Pathology at the Brigham and Women's Hospital. He received his Ph.D. in Biomedical Imaging from the Okinawa Institute of Science and Technology, Japan and was a postdoctoral fellow at the department of biomedical engineering at Johns Hopkins University. His research interests include pathology image analysis, morphological feature, and biomarker discovery using data fusion and multimodal analysis.

Publications

• Research Article   
  Safety and Efficacy of Convalescent Plasma Treatment in COVID-19 Patients: Collate Trial
  Author(s): Muhammad Hasan, Mohammad Usman Shaikh, Muhammad Jehangir Malik, Bushra Jamil, Nosheen Nasir, Kiren Habib, Adil Aziz, Iffat Khanum, Aisha Ilyas, Ramla Ghafoor, Natasha Ali* and Faisal Mahmood
  
  Introduction: The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred initially in December 2019 in the city of Wuhan, Hubei province, China where patients mainly presented with respiratory symptoms. In Pakistan the first case was identified on February 26, 2020 and since then Aga Khan University Karachi is at the forefront of the fight against COVID-19. After receiving all required approvals, this trial was undertaken to determine safety and efficacy of transfusing Convalescent Plasma (CP) in patients admitted with COVID-19. Methods: This was a non-randomized, open label, phase II clinical trial with 110 cases and 34 controls recruited during April 2020 till July 2020. Convalescent plasma donors and patients who received it were recruited using donor eligibility criteria issued by U.S. Departmen.. View more»
  

  DOI: 10.35248/2157-7560.21.12.448

  Abstract HTML PDF